High sensitivity, homogeneous particle-based immunoassay for thyrotropin (Multipact).
We describe the first homogeneous, nonradioactive, high-sensitivity assay for human thyrotropin (TSH). The assay is based on particle immunoassay techniques, wherein 800-nm particles form the basis for the immunochemistry, delivery, and the detection technologies, respectively. Our assay also is the first to involve the use of fragmented monoclonal antibodies (to eliminate serum interferences) covalently coupled to particles without loss of their binding properties. Assays are performed in a semiautomated mode with use of a new modular system (Multipact). Equilibrium is reached in less than 2 h. Precision profile, sensitivity, and clinical studies indicate that the assay is accurate, has good precision at low concentrations, and that detection-limit characteristics compare well with those of a leading commercial high-sensitivity immunoradiometric assay (IRMA) for TSH. Dilution characteristics were satisfactory down to the assay's detection limit for a range of clinical samples. Correlation studies vs a reference IRMA method yielded the regression equation, present method = 0.976 (IRMA) + 0.002 milli-int. unit/L (r = 0.98), for 223 samples with TSH concentrations in the range 0 to 30 milli-int. units/L. For 40 samples with TSH less than or equal to 1.0 milli-int. unit/L it was: present method = 0.94 (IRMA) + 0.005 milli-int. unit/L (r = 0.96).
Wilkins
T A
TA
Acade Diagnostic Systems SA, Louvain La Neuve, Belgium.
Brouwers
G
G
Mareschal
J C
JC
Cambiaso
C L
CL
D000911:Antibodies, Monoclonal; D001322:Autoanalysis; D006801:Humans; D007118:Immunoassay; D007700:Kinetics; D011786:Quality Control; D011863:Radioimmunoassay; D012016:Reference Values; D013972:Thyrotropin / Q000097:blood*
D000911:Antibodies, Monoclonal; D013972:Thyrotropin